| Literature DB >> 36081545 |
Jung Wook Suh1, Jihoon Park2, Jeehye Lee1, In Jun Yang1, Hong-Min Ahn1, Heung-Kwon Oh1, Duck-Woo Kim1, Sung-Bum Kang1.
Abstract
Purpose: Presence of a long remnant sigmoid colon after left hemicolectomy with inferior mesenteric vein (IMV) ligation for distal transverse and descending colon cancers may be a risk factor for venous ischemia. This study aimed to evaluate the clinical impact of IMV preservation in patients who underwent left hemicolectomy with inferior mesenteric artery (IMA) preservation.Entities:
Keywords: colon cancer; inferior mesenteric vein; laparoscopic surgery; left hemicolectomy; low ligation
Year: 2022 PMID: 36081545 PMCID: PMC9445569 DOI: 10.3389/fonc.2022.986516
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Preserved inferior mesenteric vein after dissection of lymph nodes around the inferior mesenteric vein. The left side of the figure is the cranial side, and the right side is the caudal side. The triangles indicate the skeletonized inferior mesenteric vein, and the arrow indicates the ligation of the left colic vein.
Figure 2Intestinal complications on computed tomography or colonoscopy during follow-up. (A) Anastomotic ulcer. (B) Anastomotic stricture. (C) Venous engorgement at the remnant distal bowel. (D) Colitis with thickened colon wall at the remnant distal bowel.
Figure 3Inferior mesenteric vein preservation confirmed on computed tomography images before (A) and after surgery (B) Triangles indicate the inferior mesenteric vein. The arrow indicates the splenic vein.
Patients’ baseline characteristics.
| Variable | IMV preservation (n = 22) | IMV ligation (n = 133) |
|
|---|---|---|---|
| Age, median (IQR), years | 63.5 (57–72) | 64.0 (56–72) | 0.947 |
| Sex, n (%) | 0.912 | ||
| Male | 14 (63.6) | 83 (62.4) | |
| Female | 8 (36.4) | 50 (37.6) | |
| Body mass index, median (IQR), kg/m2 | 24.1 (22–26) | 24.4 (22–26) | 0.776 |
| ASA grade, n (%) | 0.174 | ||
| I, II | 17 (77.3%) | 117 (88.0) | |
| III, IV | 5 (22.7%) | 16 (12.0) | |
| WBC count, median (IQR), cells/mm3 | 7.3 (6–8) | 6.1 (5–7) | 0.053 |
| Albumin, median (IQR), g/dL | 4.2 (4–5) | 4.2 (4–5) | 0.555 |
| Creatinine, median (IQR), mg/dL | 0.8 (0.7–0.9) | 0.9 (0.7–1) | 0.054 |
| cT classification, n (%) | 0.741 | ||
| cT0 | 6 (27.3) | 28 (21.1) | |
| cT1 | 3 (13.6) | 11 (8.3) | |
| cT2 | 1 (4.5) | 14 (10.5) | |
| cT3 | 9 (40.9) | 65 (48.9) | |
| cT4 | 3 (13.6) | 15 (11.3) | |
| cN classification, n (%) | 0.601 | ||
| cN0 | 15 (68.2) | 89 (66.9) | |
| cN+ | 7 (31.8) | 44 (33.1) |
Data are presented as n (%) or median (interquartile range, IQR).
IMV, inferior mesenteric vein; ASA, American Society of Anesthesiologists; WBC, white blood cell; c, clinical stage.
Peri- and post-operative outcomes and pathologic features.
| Variable | IMV preservation (n = 22) | IMV ligation (n = 133) |
|
|---|---|---|---|
|
Duration of surgery, median (IQR), min | 200 (168–214) | 185 (155–235) | 0.383 |
|
EBL, median (IQR), mL | 30 (30–45) | 100 (30–100) | 0.508 |
|
Blood transfusion, n (%) | 1.000 | ||
|
No | 0 (0) | 2 (1.5) | |
|
Yes | 22 (100) | 131 (98.5) | |
|
First passage of flatus, median (IQR), days | 3 (2–4) | 3 (2–4) | 0.864 |
|
Hospital stay, median (IQR), days | 6 (5–8) | 7 (6–8) | 0.669 |
|
Number of harvested lymph nodes, median (IQR) | 36.5 (27–44) | 37 (27–48) | 0.937 |
|
Tumor differentiation, n (%) | 0.218 | ||
|
Well/moderate | 22 (100) | 121 (91.0) | |
|
Poor/others | 0 (0) | 12 (9.0) | |
|
pT classification, n (%) | 0.267 | ||
|
pT0 | 0 (0) | 7 (5.3) | |
|
pT1 | 5 (22.7) | 32 (24.1) | |
|
pT2 | 3 (13.6) | 8 (6.0) | |
|
pT3 | 9 (40.9) | 71 (53.4) | |
|
pT4 | 5 (22.7) | 15 (11.3) | |
|
pN classification, n (%) | 0.995 | ||
|
pN0 | 14 (63.6) | 84 (63.2) | |
|
pN1 | 6 (27.3) | 36 (27.1) | |
|
pN2 | 2 (9.1) | 13 (9.8) | |
|
Lymphatic invasion (+), n (%) | 10 (45.5) | 36 (27.1) | 0.080 |
|
Venous invasion (+), n (%) | 5 (22.7) | 22 (16.5) | 0.479 |
|
Perineural invasion (+), n (%) | 10 (45.5) | 44 (33.1) | 0.259 |
Data are presented as n (%) or median (interquartile range, IQR).
Abbreviations: IMV, inferior mesenteric vein; EBL, estimated blood loss; p, pathologic stage.
Intestinal complications on computed tomography and using colonoscopy.
| IMV preservation (n = 22) | IMV ligation (n = 133) |
| |
|---|---|---|---|
|
Total, n (%) | 1 (4.5) | 31 (23.3) | 0.048 |
|
Ulcer | 0 (0) | 2 (1.5) | |
|
Stricture | 0 (0) | 4 (3.0) | |
|
Venous engorgement | 0 (0) | 4 (3.0) | |
|
Colitis | 1 (4.5) | 21 (15.8) |
Data are presented as n (%).
IMV, inferior mesenteric vein.
Morbidities in the inferior mesenteric vein ligation group.
| No. | Sex/age | Location | Findings | Tools of diagnosis | Management | Clavien–Dindo classification |
|---|---|---|---|---|---|---|
| 1 | F/67 | Distal transverse colon | Ischemic colitis | CT/Colonoscopy | Anterior resection | IIIb |
| 2 | M/58 | Splenic flexure colon | Colitis | CT | Conservative treatment | II |
| 3 | M/58 | Descending colon | Stricture | CT | Conservative treatment | II |
| 4 | M/75 | Descending colon | Colitis | CT | Conservative treatment | II |
| 5 | M/48 | Descending colon | Stricture | Colonoscopy | Colonoscopic bougination | IIIa |
No., Number; F, female; M, male; CT, computed tomography; IMV, inferior mesenteric vein.